| Effects of varying dietary content of fermentable short‐chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome TN Hustoft, T Hausken, SO Ystad, J Valeur, K Brokstad, JG Hatlebakk, ... Neurogastroenterology & Motility 29 (4), e12969, 2017 | 259 | 2017 |
| Fecal Microbiota Transplantation for Primary Clostridium difficile Infection FE Juul, K Garborg, M Bretthauer, H Skudal, MN Øines, H Wiig, Ø Rose, ... New England Journal of Medicine 378 (26), 2535-2536, 2018 | 217 | 2018 |
| Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption ST Bjørkhaug, H Aanes, SP Neupane, JG Bramness, S Malvik, ... Gut microbes 10 (6), 663-675, 2019 | 147 | 2019 |
| Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial E Birkeland, S Gharagozlian, KI Birkeland, J Valeur, I Måge, I Rud, ... European journal of nutrition 59, 3325-3338, 2020 | 132 | 2020 |
| Microbial trimethylamine-N-oxide as a disease marker: something fishy? B Landfald, J Valeur, A Berstad, J Raa Microbial ecology in health and disease 28 (1), 1327309, 2017 | 95 | 2017 |
| Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome J Valeur, MC Småstuen, T Knudsen, GA Lied, AG Røseth Digestive diseases and sciences 63, 429-436, 2018 | 90 | 2018 |
| Preterm infants have distinct microbiomes not explained by mode of delivery, breastfeeding duration or antibiotic exposure C Dahl, H Stigum, J Valeur, N Iszatt, V Lenters, S Peddada, JV Bjørnholt, ... International journal of epidemiology 47 (5), 1658-1669, 2018 | 82 | 2018 |
| Fecal fermentation in irritable bowel syndrome: influence of dietary restriction of fermentable oligosaccharides, disaccharides, monosaccharides and polyols J Valeur, AG Røseth, T Knudsen, GH Malmstrøm, JT Fiennes, T Midtvedt, ... Digestion 94 (1), 50-56, 2016 | 76 | 2016 |
| Indications of ‘atopic bowel’in patients with self‐reported food hypersensitivity K Lillestøl, L Helgeland, G Arslan Lied, E Florvaag, J Valeur, R Lind, ... Alimentary pharmacology & therapeutics 31 (10), 1112-1122, 2010 | 74 | 2010 |
| Functional bowel symptoms, fibromyalgia and fatigue: a food-induced triad? A Berstad, R Undseth, R Lind, J Valeur Scandinavian journal of gastroenterology 47 (8-9), 914-919, 2012 | 59 | 2012 |
| Fecal microbiota transplantation in systemic sclerosis: a double-blind, placebo-controlled randomized pilot trial H Fretheim, BK Chung, H Didriksen, ES Bækkevold, Ø Midtvedt, ... PLoS One 15 (5), e0232739, 2020 | 57 | 2020 |
| Perceived food hypersensitivity: a review of 10 years of interdisciplinary research at a reference center GA Lied, K Lillestøl, R Lind, J Valeur, MH Morken, K Vaali, K Gregersen, ... Scandinavian Journal of Gastroenterology 46 (10), 1169-1178, 2011 | 55 | 2011 |
| Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome MH Morken, J Valeur, E Norin, T Midtvedt, G Nysaeter, A Berstad Scandinavian journal of gastroenterology 44 (11), 1296-1303, 2009 | 53 | 2009 |
| Tryptophan:‘essential’for the pathogenesis of irritable bowel syndrome? A Berstad, J Raa, J Valeur Scandinavian journal of gastroenterology 49 (12), 1493-1498, 2014 | 50 | 2014 |
| Changes in faecal short-chain fatty acids after weight-loss interventions in subjects with morbid obesity PG Farup, J Valeur Nutrients 12 (3), 802, 2020 | 48 | 2020 |
| Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome M El‐Salhy, J Valeur, T Hausken, J Gunnar Hatlebakk Neurogastroenterology & Motility 33 (2), e13983, 2021 | 47 | 2021 |
| Impact of HIV and type 2 diabetes on gut microbiota diversity, tryptophan catabolism and endothelial dysfunction H Hoel, M Hove-Skovsgaard, JR Hov, JC Gaardbo, K Holm, M Kummen, ... Scientific reports 8 (1), 6725, 2018 | 46 | 2018 |
| Abnormal accumulation of intestinal fluid following ingestion of an unabsorbable carbohydrate in patients with irritable bowel syndrome: an MRI study R Undseth, A Berstad, NE Kløw, K Arnljot, KS Moi, J Valeur Neurogastroenterology & Motility 26 (12), 1686-1693, 2014 | 45 | 2014 |
| Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome M El‐Salhy, AB Kristoffersen, J Valeur, C Casen, JG Hatlebakk, OH Gilja, ... Neurogastroenterology & Motility 34 (1), e14200, 2022 | 44 | 2022 |
| Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota … T Mazzawi, T Hausken, JR Hov, J Valeur, DA Sangnes, M El-Salhy, ... Scandinavian Journal of Gastroenterology, 2019 | 41 | 2019 |
